173 related articles for article (PubMed ID: 8181412)
1. Colon carcinoid tumors. A population-based study.
Spread C; Berkel H; Jewell L; Jenkins H; Yakimets W
Dis Colon Rectum; 1994 May; 37(5):482-91. PubMed ID: 8181412
[TBL] [Abstract][Full Text] [Related]
2. Colonic carcinoid tumors: a clinicopathologic study of 23 patients from a single institution.
Waisberg DR; Fava AS; Martins LC; Matos LL; Franco MI; Waisberg J
Arq Gastroenterol; 2009; 46(4):288-93. PubMed ID: 20232008
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
Shebani KO; Souba WW; Finkelstein DM; Stark PC; Elgadi KM; Tanabe KK; Ott MJ
Ann Surg; 1999 Jun; 229(6):815-21; discussion 822-3. PubMed ID: 10363895
[TBL] [Abstract][Full Text] [Related]
4. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.
Ballantyne GH; Savoca PE; Flannery JT; Ahlman MH; Modlin IM
Cancer; 1992 May; 69(10):2400-5. PubMed ID: 1568162
[TBL] [Abstract][Full Text] [Related]
5. Rectal carcinoids: the most frequent carcinoid tumor.
Jetmore AB; Ray JE; Gathright JB; McMullen KM; Hicks TC; Timmcke AE
Dis Colon Rectum; 1992 Aug; 35(8):717-25. PubMed ID: 1643994
[TBL] [Abstract][Full Text] [Related]
6. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Burke AP; Thomas RM; Elsayed AM; Sobin LH
Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of carcinoids of the large intestine].
Soga J
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2318-24. PubMed ID: 2425747
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer.
Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Verlind E; Hermans J; Poppema S; Buys CH; Plukker JT
Dis Colon Rectum; 2001 Mar; 44(3):358-63. PubMed ID: 11289281
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
Correia Sda S; Pinto C; Bernardo J
Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
[TBL] [Abstract][Full Text] [Related]
10. Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature.
Soga J
J Exp Clin Cancer Res; 1998 Jun; 17(2):139-48. PubMed ID: 9700573
[TBL] [Abstract][Full Text] [Related]
11. Carcinoid tumors of the colon. A study of 72 patients.
Rosenberg JM; Welch JP
Am J Surg; 1985 Jun; 149(6):775-9. PubMed ID: 2409828
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
[TBL] [Abstract][Full Text] [Related]
13. [Surgical therapy of carcinoid tumors of the gastrointestinal tract].
Böttger T
Zentralbl Chir; 2001 Sep; 126(9):676-81. PubMed ID: 11699282
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
17. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine carcinomas of the colon and rectum.
Bernick PE; Klimstra DS; Shia J; Minsky B; Saltz L; Shi W; Thaler H; Guillem J; Paty P; Cohen AM; Wong WD
Dis Colon Rectum; 2004 Feb; 47(2):163-9. PubMed ID: 15043285
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.
Saclarides TJ; Szeluga D; Staren ED
Dis Colon Rectum; 1994 Jul; 37(7):635-42. PubMed ID: 8026228
[TBL] [Abstract][Full Text] [Related]
20. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.
Aytac E; Ozdemir Y; Ozuner G
J Visc Surg; 2014 Feb; 151(1):3-7. PubMed ID: 24412088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
